Merial Unveils New IVOMEC(R) Plant in Brazil

Nov 05, 2003, 00:00 ET from Merial

    PAULINIA (SP, Brazil), Nov. 5 /PRNewswire-FirstCall/ -- Alan Reade,
 Executive Chairman of Merial Ltd, today inaugurated a new endectocide plant at
 Paulinia, Brazil, representing an investment of $US 9m. Merial has invested
 $US 25m in its manufacturing plants in Brazil over the past six years.
     The inauguration was attended by Mr. Kurt Hausmann, Merial's Vice-
 President for Global Manufacturing and Mr. Jorge Sole, Vice-President for
 Latin America. Representatives of the Ministry of the Agriculture, Livestock
 and Supply, state and federal government officers, Merial customers and animal
 health industry representatives were also invited.
     The production capacity for the new plant is 150 million doses per year of
 IVOMEC(R) Ivomec(R) Gold, and DUOTIN(R) injectable formulations for use in
 livestock. An additional 60 jobs will be created at Paulinia to support the
 increase in production. "This is the largest animal health plant of its kind
 in the Southern Hemisphere", summarizes the Executive Chairman, Alan Reade,
 who came to Brazil especially for its inauguration.
     The plant was planned and built according to the strict requirements of
 the Food and Drug Administration (FDA) to enable exports to the USA and
 incorporates the highest levels of safety and environmental requirements. When
 approved by the FDA, this will be the first plant producing animal health
 products in Brazil able to export to the United States.
     "With the new plant, Merial Brazil becomes a global supplier of cattle
 endectocides to other Merial subsidiaries," states Jorge Sole. The Brazilian
 affiliate currently exports, among other products, IVOMEC(R) Gold, -- a unique
 injectable long acting endectocide formulation for use in cattle -- to Latin
 America, South Africa and, in the near future, to Australia, New Zealand and
 other markets.
     "It is the most modern plant for Merial animal health products worldwide,"
 emphasizes Kurt Hausmann.
     About Merial
     Merial is a world leading innovation-driven animal health company,
 providing a comprehensive range of products to enhance the health, well-being
 and performance of a wide range of animals. Merial employs around 6,000 people
 and operates in more than 150 countries world-wide. Its 2002 sales were in
 excess of $1.7 billion.
     Merial is a joint venture between Merck & Co., Inc. (NYSE:   MRK) and
 Aventis S.A. (NYSE:   AVE). For further information please see